EVONETIX develops technology for gene synthesis, aiming to contribute to the biology revolution.

Evonetix Ltd

EVONETIX

We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists'​ ability to use synthetic biology on a scale not currently possible. 

Innovate UK

Cambridge Consultants

Morningside Group

DCVC

Molten Ventures

Foresite Capital

Providence Investment Company Limited

Page One Ventures

Civilization Ventures

We're developing a novel silicon array that actively controls #DNAsynthesis, gene assembly and error correction at thousands of discrete sites across its surface. 

Our technology aims to put ultra-parallel #DNA preparation in the hands of researchers, enabling faster turn around and iteration at a scale currently only available in major service centres.

Gene synthesis will turn from a major bottleneck into the opportunity to drive forward the scope and ambition of #syntheticbiology.

Take a look at how it works: https://lnkd.in/gx-qX53v

Engineering biology is already shaping the world for the better, but a transformation in gene synthesis capabilities is needed before it can reach its potential. Our mission is to ignite the #engineeringbiology revolution by putting a gene foundry in every lab.  
 
Find out more below. 
www.evonetix.com

#sytheticbiology #DNA

Next week, our team will be attending the Synthetic and Engineering Biology British-Swiss Summit – a collaborative venture between academics and industry leaders to discuss how we can address healthcare and environmental challenges. 

This year’s summit includes an exciting programme of presentations from the latest advances in cell engineering to scale-up in bioprocessing and AI-driven solutions.

Check out the full agenda here: https://rb.gy/6btcev

#SynBio #EngineeringBiology #GeneSynthesis

Great to meet up with friends and colleagues in the synthetic biology space at this year’s SynBioBeta.
 
Thanks to the BioIndustry Association (BIA) for organising the UK Pavilion, showcasing the great companies shaping synthetic and engineering biology in the UK.
 
Find out more here: https://rb.gy/15dvft
 
#EngineeringBiology #SyntheticBiology #DNA

We’ll be in San Jose for #SynBioBeta2024 next week, joining industry leaders to discuss the transformative nature of synthetic biology and how it can revolutionize healthcare and other industries.
 
With sessions exploring the crucial role of gene synthesis in DNA-driven innovations, from treating disease to addressing some of the challenges presented by the planet, and the importance of biosecurity as the world of synthetic biology is rapidly expanding.
 
See the full agenda here: https://rb.gy/i5kpgr
 
#EngineeringBiology #SyntheticBiology #GeneSynthesis #DNA

We're looking forward to attending SynBioBeta next month as part of BioIndustry Association (BIA)’s UK Pavilion, alongside a network of industry leaders who are committed to using biology to build a better world. 
 
From engineers to investors, innovators, and entrepreneurs, The Global Synthetic Biology Conference gathers a broad range of individuals who share a passion for biological engineering to discuss the industry's latest innovations and cutting-edge technologies and how they are addressing some of the world's greatest challenges.
 
Find out more here: https://rb.gy/hzei35
 
#EngineeringBiology #SyntheticBiology #Sustainability

EVON

COM:EVONETIX

EVONETIX

locale

market

industry

website

linkedin

founding date

peer of

investor of

Metrics